(Alliance News) - UK Business Secretary Jonathan Reynolds is set to confirm the government will consult on easing rules related to the phasing-out of new petrol and diesel cars, the PA news agency ...

(Alliance News) - JPMorgan Global Core Real Assets Ltd on Wednesday said its loss narrowed in the first half of its current financial year, as the firm progresses its managed wind-down. The investment ...

(Alliance News) - Autins Group PLC on Wednesday said its loss widened and revenue fell due to low automotive demand levels and delayed new vehicle introductions. The Rugby, England-based maker of ...

The FTSE 100 index added 4.24 points, 0.1%, at 8,262.85. The FTSE 250 rose 15.49 points, 0.1%, at 20,584.14, and the AIM All-Share added 1.29 points, 0.2%, at 731.88. The Cboe UK 100 was flat at ...

The suspension of shares on the ASX and the Johannesburg Stock Exchange was lifted. Trading on the London Stock Exchange's AIM continued as normal as it was not temporarily suspended before the ...

(Alliance News) - Tectonic Gold PLC on Wednesday reported a narrowed loss for its financial year ended June 30, reflecting improved cost controls and a shift in strategy following asset transactions.

(Alliance News) - Transense Technologies PLC on Wednesday said revenue and profit are up compared to last year and it expects to perform "at least in line" with market expectations. Oxfordshire, ...

Nationwide said that, since buying Virgin Money, it has booked an accounting gain of GBP2.3 billion, based on the value of the net assets acquired being above the price paid. Virgin Money also ...

In response, Iomart cut its interim dividend by 33% to 1.30 pence per share from 1.94p a year prior. In early October, Iomart announced an agreement to acquire Kookaburra Topco Ltd, the holding ...

(Alliance News) - Strix Group PLC on Wednesday said in a trading update that it expects to report a fall in annual profit for 2024, following weaker trading in the second half of the year and cost ...

The Finland-based developer of cancer immunotherapies said 20 patients with myelodysplastic syndrome, a rare blood cancer, had showed an 80% objective response rate in the ongoing BEXMAB trial.

Looking ahead, Gateley expects to deliver full-year results in line with market expectations, citing a company-compiled market consensus of GBP184 million in revenue, which would represent a 6.5% ...